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ABSTRACT: Larrea divaricata Cav. (Zygophyllaceae) is an autochthonous plant of 
South America, widely distributed in Argentina. It is used in folk medicine as an 
anti-inflammatory drug. By other way, presents well documented antitumoral and 
immunomodulatory effects. Nordihydroguaiaretic acid (NDGA), an antioxidant 
compound, had been previously described in this plant. Nowadays a formulation for 
hair growth based on an extract of L divaricata is commercialized in Argentina. 
Taken these into account, the objective of this work was to determine the systemic 
and local toxicities of the aqueous extract of L divaricata, by giving it under oral and 
topical administration. Also, it was proposed to analyze the participation of NDGA 
in the systemic toxicity of the plant extract. The extract presented low acute toxicity, 
and the histopathological examination of the tissues did not show any signal of 
toxicity at the same time that did not affect biochemical parameters except 
eosinophils which were decreased by the treatment. Which is more; the extract did 
not exert dermatological or ocular irritation. It is important to note that in relation to 
its innocuousness and pharmacological properties other phytotherapy formulations 
could be prepared in a future. 
INTRODUCTION: Larrea divaricata Cav. 
(Zygophyllaceae) is an autochthonous plant of 
South America widely distributed in Argentina. It 
is used in folk medicine as an anti-inflammatory 
drug. The aqueous extract possesses well 
documented activities such as antiproliferative, 
antimicrobial 
1, 2
 and antioxidant activity 
3, 4
.  The 
antiproliferative and immunomodulatory activities 
of the aqueous extract (AE) of the leaves had been 
well documented “in vitro” 5, 6. 
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Also, “in vivo” antitumoral activity of the aqueous 
extract, in a dose from 25 to 250 mg/kg, was shown 
in female rats with mammary carcinomas 
chemically induced with N-nitroso-N methylurea 
5, 
7
. By other way, the “in vivo” immunomodulatory 
activity in mice was demonstrated at a dose of 15 
mg/kg 
4, 8
.  
 
By other way, nordihydroguaiaretic acid (NDGA), 
which is known to be an antioxidant compound, 
previously described in this plant 
9 
was prohibited 
by FDA due to its hepatic and renal toxicities.  
Previously an acute toxicity study was performed 
with the extract but NDGA was not studied in 
comparison with this 
7
. Nowadays a formulation, 
based on an extract of L divaricata, used as a 
topical hair growth increaser, is commercialized in 
Argentina. It is worth try to study the toxicity of the 
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plant extract in regards to its pharmacological 
properties and the fact that other phytotherapy 
formulations could be prepared in a future. 
 
Taken into account, the objective of this work was 
to determine the systemic and local toxicities of the 
aqueous extract from L divaricata by giving the 
extract under oral and topical administration. Also, 
it was proposed to analyze the participation of 
NDGA in the systemic toxicity of the plant extract. 
This study revealed that the extract was not toxic. 
 
 MATERIALS AND METHODS: 
 Plant material and preparation of the extract: 
Leaves of Larrea divaricata Cav. were collected in 
the province of Córdoba, Argentina and identified 
using morphological, anatomical and histochemical 
analyses. A voucher specimen (BAFC N° 38) was 
deposited in the Museum of Pharmacobotany, 
School of Pharmacy and Biochemistry, University 
of Buenos Aires.  
 
An aqueous extract (AE) of the leaves was 
prepared at 7.5 %. For this the air-dried leaves were 
extracted for 10 min with boiling distilled water, 
then, the extract was filtered and lyophilized. The 
final yield was 26.6 g % of plant material. AE was 
aliquoted and stored at -20°C until used 
5
. 
 
Phytochemical studies: 
HPLC analysis: 
The HPLC analysis was performed in a Varian Pro 
Star instrument equipped with a Rheodyne 
injection valve (20 µl) and Photodiode array 
detector set at 280 nm A reversed-phase column 
Phenomenex – C18 (2) Luna (250 mm x 4.6 mm 
and 5 μ dp) was used. As mobile phases, water and 
acetic acid (98:2, mobile phase A) and methanol 
and acetic acid (98:2, mobile phase B) were 
employed, The gradient was from 15 % B to 40 % 
B in 30 min; 40 % B to 75 % B in 10 min; 75 % B 
to 85 % B in 5 min and 100 % B in 5 min. Mobile 
phase B was kept at 100 % for 10 min before 
restoring the initial conditions. Mobile phases were 
delivered with a flow rate of 1.2 ml/min. The 
chromatographic procedure was performed at room 
temperature (18-25ºC). Pure standard of NDGA 
(Sigma (USA)) was used for identification and 
quantification by comparing retention times and by 
plotting peak areas respectively 
9
.  
Determination of total polyphenols:  
The lyophilized extract was weighted and dissolved 
in distilled water. Total polyphenols was 
determined by spectrophotometry according to the 
Folin-Ciocalteu method 
10
 using gallic acid as 
standard. Briefly, 1.0 ml of this sample extract was 
transferred to separate tubes containing 7.0 ml 
distilled water, 0.5 ml of Folin–Ciocalteu´s reagent, 
and 1.5 ml of a 20% anhydrous sodium carbonate 
solution. The mixture was then allowed to stand at 
room temperature for 60 min and then the 
absorbance at 765 nm was measured by employing 
a spectrophotometer. The concentration of 
polyphenols in samples was derived from a 
standard curve of gallic acid ranging from 10 to 50 
g/ml (Pearson´s correlation coefficient: r2 = 
0.9996).  
 
Animals:  
Seven week old female and male C3H/He mice 
were provided by Dr. Norberto San Juan 
(Department of Microbiology Faculty of Medicine, 
University of Buenos Aires and maintained on a 
standard laboratory diet and water “ad libitum”. 
Animals were housed at the Animal Resource 
Facilities, Faculty of Pharmacy and Biochemistry, 
University of Buenos Aires, in accordance with 
institutional guidelines. The experimental designs 
were approved by the institutional animal research 
committee from Faculty of Pharmacy and 
Biochemistry, University of Buenos Aires, 
(Number: 220612-1) and experiments were 
conducted in accordance with the internationally 
accepted principles for laboratory animal use and 
care (Guide for the Care and Use of Laboratory 
Animals, U.S.  National Research Council, 1996). 
 
Systemic toxicity studies: 
Acute toxicity: 
A modified method of Litchfield and Wilcoxon 
was used to assess the acute toxicity of L. 
divaricata and NDGA. Female mice were fasted 
for 16 h and divided into three groups of five 
animals per dose. The treatments were 
administered orally by using an intubation’s 
cannula. L. divaricata extract was administered 
from 20 to 50000mg/kg, and NDGA from 2.5 to 
1000mg/kg. The control group received 0.2 ml of 
physiological saline orally. Both, the test and 
control animals were then allowed to access to food 
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and water “ad libitum” and were observed over a 
period of 15 days for signs of acute toxicity. The 
number of deaths in each group of animals within 
the period of observation was recorded. On day 15, 
mice were euthanized, gross observations were 
recorded and necropsies were performed. 
 
The median lethal dose (LD50) of the plant extract 
was calculated from data extrapolated from 
concentration-response curves, using a 
mathematical method based upon the principles of 
a right-angled triangle: LD50: D- [(A-50 % max 
response). X]/ Y; A: immediately superior response 
of 50 % max response; D: log concentration 
corresponding to A response; X:  D-C; Y: A-B; B: 
immediately inferior response of 50 % max 
response; C: log concentration corresponding to B 
response. 
 
Sub-chronic oral toxicity: 
The sub-chronic oral toxicity was performed in 
accordance to the instructions laid down by OECD 
test guideline number 407
11
. Fifty mice were 
divided into 5 groups of 10 animals (5 females and 
5 males). The extract, re-suspended in distilled 
water was administered to different groups of mice 
at the dose levels of 25, 50, 250mg/kg respectively,  
1mL of different concentrations of the extracts 
were administered by using an intubation’s 
cannula, one group that receive physiological saline 
was considered as control.  The doses were selected 
in accordance to the “in vivo” previous studies 5, 7, 8, 
4
. Other group was treated with a dose of NDGA 
1.45mg/kg (this dose represents the approximate 
amount of NDGA found in 250mg/kg of AE, 
quantified by HPLC).  
 
At the end of the study, blood was collected, from 
cardiac puncture of 5 females and five males per 
group, into EDTA coated and uncoated containers. 
A complete blood test using an automated analyzer 
Coulter LH 750 (Beckman, Pasadena, California, 
USA) was performed. Red blood cell (RBC), 
hemoglobin (HGB),  hematocrit (HCT), mean 
corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), mean corpuscular hemoglobin 
concentration (MCHC), red blood cell distribution 
width (RDW), white blood cells (WBC),  
neutrophil,  eosinophil,  basophil, lymphocyte, 
monocyte and platelets were determined. Alanine 
aminotransferase (ALT) activity (IU/L) was 
determined in serum of extract/NDGA-treated or 
untreated mice using a commercial kit (Wiener 
Lab. Rosario. Argentina), cholesterol (mg %) and 
triglycerides (mg %) were evaluated by 
colorimetric methods. Also creatinine (mg/dl) was 
determined in serum of mice using a kinetic-
colorimetric method.  
 
Immediately after blood extraction, treated and 
untreated animals were sacrificed and autopsied. 
Briefly, organs were weighted and 3–5 mm thick of 
several tissue pieces were fixed in 10% formal-
saline (0.9% NaCl in 10% formaldehyde) for 24 h 
and washed in running water for another 24 h. 
Samples were dehydrated by passing through 50, 
70, 90, and 100% alcohol over a 2-day period, and 
then cleared in benzene to remove alcohol until the 
tissues became transparent. Then the samples were 
stained with haematoxylin–eosin and examined by 
using light microscope. 
 
CNS toxicity: 
Tail suspension test: 
To evaluate the toxicity in central nervous system, 
such as the depressant or stimulant action, 30 
animals were separated  into three groups of  ten 
animals (5 females and 5 males), one group was 
treated with AE (250mg/kg), other with NDGA 
(1.45mg/kg) and a third group with saline (control 
group) by oral administration as explained before. 
After a treatment of 28 days, animals were 
suspended by the tail with adhesive tape placed at 1 
cm from the tip of the tail. Immobility time during 
a period of time of 6 min was recorded with an 
automated electromechanical strain gauge device 
and stored on a computer equipped with the 
relevant software (Med Associates Inc., Georgia, 
USA)
12
  
 
Forced swimming test: 
For this test, 30 animals were separated into three 
groups of ten animals (5 females and 5 males), one 
group was treated with AE (250 mg/kg), and other 
with NDGA (1.45 mg/kg) and a third group with 
saline (control group) by oral administration as 
explained before. The animals were individually 
placed in a beaker (16 cm in diameter) filled with 
20cm water maintained at 23.5–24.5 ◦C. A mouse 
was judged to be immobile when it floated in the 
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water, in an upright position, and made only small 
movements to keep its head above water. The 
duration of immobility was recorded during the last 
4 min of the 6-min test. A decrease in the duration 
of immobility is indicative of an antidepressant-like 
effect. The test period was automatically recorded 
by a camera mounted above the cylinders and 
stored on a computer equipped with the relevant 
software (Viewpoint, Viewpoint Life Sciences, 
France). 
 
Local toxicity 
Primary acute-irritation dermal test: 
To test the irritant and toxic properties of L. 
divaricata extract on the skin, the Draize test was 
used. Briefly, 0.5 ml of L. divaricata extract (1000 
mg/ml, concentration used for local uses) was 
applied to the intact and abraded skin of six male 
New Zealand White (NZW) rabbits. The treated 
zones were covered and observed 24 and 72 h after 
treatment. The erythema and edema scores for each 
site were monitored. The results were expressed 
considering the following reference values of 
dermic irritation: 0-1: No irritant; 1-2: Minimally 
irritating, 2-6: Moderately irritating;  6: Extremely 
irritating  
 
Ocular irritation test: 
The acute ocular irritation study was performed to 
assess the potential irritancy of L. divaricata extract 
in the rabbit eyes. Twelve NZW rabbits, weighing 
2.13–2.58 kg and approximately 12–20 weeks of 
age, were acclimatized for at least 5 days prior to 
the study. A volume of 0.1 ml of the test material 
(1000 mg/ml) was instilled into right eyes. The left 
eye remained untreated and was used for control 
purposes. Assessment of ocular damage/irritation 
was made at approximately 1, 24, 48 and 72h 
following treatment, according to the numerical 
evaluation given in Appendix I of Draize. Any 
other ocular effects were also noted. Examination 
of the eyes was facilitated by using a standard 
ophthalmoscope. An additional observation was 
made on day 7 to assess the reversibility of the 
ocular effects
13
. 
 
Statistical analysis: 
Student´s t test was used to compare mean values 
between two groups and for multiple comparisons, 
ANOVA plus Dunnett´s test was used. A p  0.05 
was considered statistically significant. 
 
RESULTS: 
Firstly, the total polyphenol content was 
determined to standardize the extract. The extract 
presented a concentration of polyphenols of 11.395 
± 0.57 mg GAE/ g extract. The chromatographic 
profile of AE showed a peak corresponding to 
NDGA (0.30 g % w/w) with a retention time at 
43.2 min (Fig.1). 
 
 
FIG. 1: CHROMATOGRAPHIC PROFILE OF AE FROM L. 
DIVARICATA CAV. AND NDGA STANDARD BY HPLC.  
 
Secondly, the acute toxicity was determined but 
only in female mice. The LD50 of AE was 4466 
mg/kg meanwhile NDGA presented a value of 77 
mg/kg (Fig. 2).  
 
 
FIG. 2: MORTALITY CURVES OF L. DIVARICATA AND NDGA. L. 
DIVARICATA OR NDGA WAS ADMINISTERED IN FEMALE MICE 
AT DIFFERENT DOSES. THE NUMBER OF DEATHS IN EACH 
GROUP OF ANIMALS WITHIN THE PERIOD OF OBSERVATION 
WAS RECORDED. DOSE/RESPONSE (% DEATH) CURVE WAS 
THEN USED TO CALCULATE THE MEDIAN LETHAL DOSE LD50 
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No deaths were registered with control animals. 
None of  the treated animals showed any clinical 
sign of abnormalities during their gross 
examination of skin, fur, eyes, mucous membrane, 
respiratory, circulatory, autonomic, central nervous 
systems and behavioral pattern. Even no signs of 
tremors, convulsions, salivation, diarrhea and coma 
were recorded after the administration of the 
extract. Patho-physiological observations of the 
organs revealed no visible lesions in any animals. 
Then, the sub-acute toxicity was determined at 
selected doses, chosen from the animal’s “in vivo” 
studies. Treated animals did not show any sign of 
mortality during the repeated dose 28-day oral 
toxicity study. No abnormality was observed in the 
ophthalmic, autonomic, central nervous system, 
somato-motor activity and behavior pattern that 
were considered to be biologically significant either 
with AE or NDGA (Table 1). 
 
TABLE 1: PRELIMINARY OBSERVATION AND SCREENING EFFECT OF AE UP TO 48 HS AFTER ADMINISTRATION  
        Remarks: - No effect 
 
No significant change of terminal bodyweight was 
recorded between the normal control and the 
treatment groups of both male and female animals 
with both treatments (data no shown). The 
hematology and biochemistry blood parameters did 
not appear to be affected by AE in any dose  
 
assayed or by NDGA as no significantly 
differences were noticed between treatments and 
controls. The only parameter affected with the 
treatments was eosinophils number which was 
decreased by AE and NDGA in all doses (Table 2 
presented results obtained with the maximum dose 
assayed).  
 
TABLE 2: BLOOD SIMPLE ANALYSIS FROM TREATED AND UNTREATED MICE WITH AQUEOUS EXTRACT OF L. 
DIVARICATA 250 MG/KG AND NDGA 1.45 MG/KG. 
      A 
               B 
 
 
 
 
 
 
 
Results represented mean ± S.E. of five animals. F: female mice; M: male mice. ** p ≤ 0.01 respect to control value. C: control; NDGA: 
nordihydroguaiaretic acid  AE: aqueous extract, RBC: Red blood cell, HGB: hemoglobin, HCT: hematocrit, MCV: mean corpuscular volume, 
MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, RDW:  red blood cell distribution width, WBC: 
white blood cells, N: neutrophil, E: eosinophil, B: basophil, L: lymphocyte, M: monocyte and P: platelets 
Clinical Signal Time (Hs) 
 0.5 1 2 6 24 48 
 CNS stimulation 
Hyperactivity - - - - - - 
Piloerection - - - - - - 
Twitchting - - - - - - 
Rigidity - - - - - - 
Irritability - - - - - - 
Jumping clonic - - - - - - 
Convulsions - - - - - - 
Tonic convulsions - - - - - - 
Ptosis - - - - - - 
 CNS depression 
Sedation - - - - - - 
Loss of pinna - - - - - - 
Reflux catatonia - - - - - - 
Loss of muscle tone - - - - - - 
 RBC WBC HGB HCT MCVC MCH MCHC RDW N E B L M P 
C F 7.2 ± 0.6 5.8 ± 0.3 12.2 ± 1.0 36.0 ± 3.0 49.0± 5.0 16.8 ± 1.0 34.3± 3.0 12.8 ± 1.0 37.5 ± 9.0 5.0 ± 0.6 0 ±0 56.3 ± 8.5 9.0 ± 0.8 727.0 ± 60 
C M 8.2 ± 0.9 6.0 ± 0.6 13.2 ± 1.0 38.0 ± 3.0 51.0± 5.0 18.8 ± 1.0 36.3± 3.0 13.8 ± 1.0 38.5 ± 9.0 6.0 ± 0.6 0 ± 0 58.3 ± 8.5 9.8 ± 0.8 737.0 ± 70 
NDGA F 7.3 ± 0.5 4.8 ± 0.5 11.9 ± 0.9 33.0 ± 3.0 48.0 ± 4.0 17.5 ± 2.0 35.5± 4.0 13.0 ± 0.9 30.5 ± 5.0 1.8 ± 0.6** 0 ± 0 62.5 ± 6.0 7.5 ± 7.0 715.0 ± 70 
NDGA M 8.3 ± 0.5 6.8 ± 0.5 14.9 ± 0.9 34.0 ± 3.0 50.0 ± 6.0 19.5 ± 2.0 37.5± 5.0 13.6 ± 0.9 36.5 ± 5.0 1.9 ± 0.5** 0 ±0 59.5 ± 6.0 8.5 ± 7.0 730.0 ± 70 
AE F 7.0 ± 0.6 4.9 ± 0.4 12.3 ± 1.0 34.0 ± 2.0 49.7 ± 5.0 18.1 ± 1.0 36.3± 4.0 12.7 ± 1.0 32.0 ± 5.0 2.0 ± 0.2 ** 0 ±0 64.8 ± 7.5 6.8 ± 8.0 788.0 ± 70 
AE M 8.0 ± 0.6 6.9 ± 0.4 14.3 ± 1.0 38.0 ± 2.0 55.7 ± 5.0 19.1 ± 1.0 38.6± 4.0 14.7 ± 1.5 35.0 ± 5.0 2.8 ± 0.2 ** 0 ±0 62.8 ± 7.5 7.5 ± 8.0 786.0 ± 80 
 Cholesterol (mg%) Triglycerides (mg%) Creatinine (mg/dl) Alanine transaminase ( IU/L) 
C F 91.0 ± 4.2 146± 5.6 0.32 ± 0.02 28.0 ± 6.0 
C M 92.0 ± 5.0 150± 6.6 0.37 ± 0.04 29.0 ± 5.0 
NDGA F 92.5 ± 4.0 152 ± 9.0 0.34± 0.02  29.0± 6.8 
NDGA M 94.0 ± 8.0 158 ± 10 0.36± 0.03  30.0± 5.0 
AE F 95.5 ± 3.5 154 ± 5.6  0.28 ± 0.01 20.0 ± 5.0 
AE M 96.0 ± 9.5 155 ± 10  0.32 ± 0.04 25.0 ± 5.0 
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Moreover, no histological changes were observed 
in the organs analyzed with AE in different doses 
or NDGA (Table 3 presented results with the 
maximum dose assayed).  
 
TABLE 3:  HISTOPATHOLOGICAL INVESTIGATION OF SEVERAL ORGANS FROM TREATED AND 
UNTREATED MICE WITH AQUEOUS EXTRACT OF L. DIVARICATA 250 MG/KG AND NDGA 1.45 MG/KG.
 
- No alterations. C: control, NDGA: nordihydroguayaretic acid, AE: aqueous extract. F: female mice; M: male mice. 
 
By other way, even though no signals of CNS 
depression or stimulation effects were observed at 
the naked eye, AE and NDGA treated animals were 
studied deeper by two methods commonly used to 
determine effects on CNS: the forced swimming  
 
and tail suspension tests. The time of immobility 
did not change with both methods in tests (female 
and male animals) in comparison with controls. 
The values obtained in female mice are represented 
in Fig. 3 as example. 
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FIG.3: FORCED SWIMMING TEST (A) AND TAIL SUSPENSION TEST (B) ASSAYED ON GROUPS OF FIVE FEMALE MICE 
TREATED WITH (AE), NDGA AND UNTREATED (CONTROL). RESULTS WERE EXPRESSED AS MEAN ± SEM.  
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-          - -          - -        -     
-        - 
-          - 
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Finally, AE did not show dermal or ocular irritation (Table 4). 
 
TABLE 4. “IN VIVO” IRRITATION TESTS IN RABBITS WITH AQUEOUS EXTRACT OF L. DIVARICATA. 
                           A 
Dermic irritation test 
Reference scores for dermal irritation  AE score 
0-1 No -irritant 0.75 
1-2 Minimum irritation  
2-6 Moderate irritation  
> 6 Hightly irritation  
                           B 
 Ocular irritation test 
Scores Time after treatment 
Signals              24 h              48 h            72 h             4 days        7 days 
* corneal opacity - - - - - 
** Iritis - - - - - 
*** Conjuntival 
inflammation 
- - - - - 
**** all signals - - - - - 
                   Remarks: - No effects 
 
DISCUSSION: In this study it was demonstrated 
that AE did not present systemic or local toxicity. 
By HPLC it was demonstrated that NDGA was the 
majority polyphenol compound found. NDGA is 
known to have antioxidant properties 
14
, because of 
this it had been employed in the conservation of 
fats and butter. Then, it was prohibited by FDA as 
consequence of its hepatotoxic effects observed at 
high concentrations. Despite the fact that NDGA 
was the majority compound, it is soluble in ethanol, 
slightly soluble in hot water and insoluble in cold 
water 
26
, this last explained why the amount of this 
compound extracted in the aqueous extracts was 
very low in comparison with alcoholic extracts 
27
. 
 
The concentrations of NDGA related to 
hepatotoxicity in tissues are in the order of 50- 100 
µM (15- 30 µg/ml) or more
28
.  In contrast, low 
concentrations between 1- 10 µM (0.3- 6µg/ml) are 
related to beneficial properties, which are of 
potential use for humans, such as: enzyme 
inhibitor, antimicrobial, protective of neuro and 
bladder toxicity
29
, anticancer and antimutagenic 
30
. 
Furthermore, it was shown that it possesses 
antimitogenic effect in mammalian hepatocytes “in 
vitro” and “in vivo” 31.  
 
The extract presented low acute toxicity because its 
LD50 was high (4.4 g/kg), previously, the acute 
toxicity of L. divaricata extract was determined in 
females and male mice but it was not compared 
with NDGA 
10
. Accordingly to the previously 
study, the LD50 in male mice (LD50: 10000 (8196 to 
12200 mg/kg)) was higher than in female mice 
(LD50:  4000 (3030 to 5276 mg/kg)). As female 
mice were more sensible than male mice in the 
present work females mice were selected to 
perform acute toxicity study with NDGA. 
 
According to Kennedy et al
32
, substances that 
present LD50 in the order of 5.0 g/kg given by oral 
route may be considered practically non-toxic. In 
regards with NDGA, as the amount of this 
compound present in the LD50 of AE, was in the 
order of 13.5 mg, quantity that did not produce any 
death or toxic signals, it could be said that NDGA 
did not contribute to LD50 of the extract.  
 
When the sub-chronic toxicity was performed, with 
the exception of eosinophils number, hematological 
and biochemical parameters remained under the 
reference range for control animals as no statistical 
significant changes were observed between groups. 
Analysis of blood parameters is relevant for risk 
evaluation, as any change in the hematological and 
biochemical systems have a higher predictive value 
for human toxicity, when data are translated from 
animal studies 
33
.  
 
The eosinophils are located in the connective 
tissues under the epithelial layer of the skin, 
bronchi, gastrointestinal tract and the wall of the 
uterus 
34
. In healthy individuals, only a small 
number of eosinophils, circulate in the blood, 
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where they remain for a short period (3 to 8 h) 
before entering the tissues. Blood and tissue 
eosinophilia are markedly augmented in individuals 
with allergic diseases or with helminthes infections 
35
.  Eosinophils secrete a variety of mediators 
which might affect the development of the 
inflammation and are involved in allergic reactions. 
The most important of these mediators are the 5-
lipoxygenase metabolites of arachidonic acid: 5-
hydroxyeicosatetraenoic acid (5-HETE) and 
leukotriene C4 (LTC4) 
36
 which are involved in the 
recruitment of other eosinophils. Some drugs such 
as corticosteroids induce eosinophenia in part 
associated with the inhibition of the synthesis of 
leukotrienes 
37
. Since the extract presented NDGA, 
which is known to inhibit 5-lipoogygenase, this 
compound could be involved in the eosinophenia 
induced by the extract. 
 
Because the extract did not modify the level of 
transaminases (ALT), cholesterol and creatinine, 
which are good indicators of liver and kidney 
functions respectively 
38
, and did not induce any 
histological damage in these organs, it could be 
hypothesize that the extract was not toxic for these 
organs.   
 
By other way, it did not exert CNS toxicity in 
relation to depressant or stimulant activity. The 
methods used in this work are widely used to detect 
potential antidepressant effects of drugs. For 
example, the forced swimming test is based on the 
observation that when rats are exposed to water, 
after initial intense escape-directed behavior, such 
as swimming and climbing, they stop struggling 
and show passive immobile behavior. A wide range 
of antidepressant treatments have been shown 
consistently to reduce the amount of immobility 
time in the test by increasing active escape 
behaviors.  In addition the extract would be safe for 
topic administration as it did not exert irritation 
signals by the methods studied. 
 
CONCLUSION: Taken together these data, it 
could be suggested that, the aqueous extract of the 
plant did not present systemic or local toxicities 
and that NDGA content was very low to exert any 
toxicity at the dose assayed. These results could 
stand the safely medicinal use of this plant in folk 
medicine and in phytomedicines. 
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